ブース番号1F-26
カテゴリー原料
パビリオン韓国パビリオン
HLB PEP CO., LTD.
小間番号：1F-26
カテゴリー：原料
パビリオン：韓国パビリオン
企業情報
Email：
order@hlbpep.co.kr
TEL： +82-62-714-1166
住所： Pilot plant-Rm. 206, Gwangju Technopark, 333 Cheomdangwagi-ro, Buk-gu, Gwangju, Republic of Korea 61008
URL：
www.hlbpep.co.kr/eng/main/
HLB PEP supplies various types of high-quality peptides promptly by applying our optimal synthesis technology and extensive experiences in the peptide synthesis.
We manufacture high-quality custom-made peptides by applying our thorough product managing system (ISO 9001, 14001, 45001, GMP Certificated) in the synthesis and purification of peptides, and we supply the peptides demanded by customers by applying custom-made synthesis and purifications according to the level of difficulty in the synthesis and types of modification.
We manufacture high-quality custom-made peptides by applying our thorough product managing system (ISO 9001, 14001, 45001, GMP Certificated) in the synthesis and purification of peptides, and we supply the peptides demanded by customers by applying custom-made synthesis and purifications according to the level of difficulty in the synthesis and types of modification.
企業情報
| 住所 | Pilot plant-Rm. 206, Gwangju Technopark, 333 Cheomdangwagi-ro, Buk-gu, Gwangju, Republic of Korea 61008 |
|---|---|
| TEL | +82-62-714-1166 |
| FAX | +82-62-714-1188 |
| URL | www.hlbpep.co.kr/eng/main/ |
| order@hlbpep.co.kr |
| 出展製品・サービス |
Leuprorelin / DMF, Ph. Eur, USP, USFDA #25878 Desmopression / DMF, Ph. Eur, USP Ganirelix / DMF, USFDA, #040573 Vasopressin / DMF scheduled for US FDA submission in 3Q 2026 Taltirelin (Oral drug) / DMF scheduled for PMDA Submission in 4Q 2026 Glucagon / DMF scheduled for PMDA Submission in 2027 |
|---|